Uncomplicated oocyte donation pregnancies display elevated CD163 positive type 2 macrophage load in the decidua, which is associated with fetal-maternal HLA mismatches

Placenta ◽  
2021 ◽  
Vol 112 ◽  
pp. e29
Author(s):  
Xuezi Tian ◽  
Kaveri T.S. Aiyer ◽  
Hanneke M. Kapsenberg ◽  
Dave L. Roelen ◽  
Marie-Louise van der Hoorn ◽  
...  
2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
K Va. Bentem ◽  
M Bos ◽  
C Va. de. Keur ◽  
H Kapsenberg ◽  
L Lashley ◽  
...  

Abstract Study question Is the number of regulatory T-cells (Tregs) and immunoregulatory cytokines in the decidua basalis of oocyte donation (OD) pregnancies different compared to naturally conceived pregnancies? Summary answer This study suggests that the immunoregulation at the fetal-maternal interface in OD pregnancies with a higher amount of fetal-maternal HLA mismatches appears to be altered. What is known already Tregs and related immunoregulatory cytokines, such as interleukins, transforming growth factor-β, and galectin–1, play a key role in maintaining tolerance at the decidua basalis in human pregnancy. Previous studies observed decreased numbers of decidual Tregs in miscarriage and preeclamptic pregnancies. These complications occur in higher frequencies in OD pregnancies, which are characterized by more fetal-maternal human leukocyte antigen (HLA) mismatches compared with naturally conceived (NC) and non-donor in vitro fertilization (IVF) pregnancies, since the fetus obtains paternal and donor-derived HLA genes. Consequently, the maternal immune system has to cope with greater immunogenetic dissimilarity. Involved immunoregulatory mechanisms however remain poorly understood. Study design, size, duration: This case-control study included 27 OD, 11 IVF, and 16 NC placentas of uncomplicated pregnancies, which were collected after delivery at 37–42 weeks of gestation between 2005 and 2013. Clinical data, maternal peripheral blood and umbilical cord blood were collected. Participants/materials, setting, methods Decidua basalis was dissected from the placentas, and processed to formalin-fixed, paraffin-embedded slices (4 µm). Immunohistochemical staining for FOXP3, interleukin 10, interleukin 6, galectin–1, transforming growth factor-β, and Flt–1 was performed. Semi-quantitative (FOXP3+ Tregs) and computerized analysis (cytokines), using Image-J software, were executed. Maternal peripheral blood and fetal umbilical cord blood were typed for HLA class I and II, using the Sequence Specific Oligonucleotides PCR technique, to calculate the number of fetal-maternal HLA mismatches. Main results and the role of chance All the deciduae basalis of OD, IVF and NC pregnancies showed FOXP3+ Tregs. No significant differences were found when comparing the three groups for the mean number of FOXP3+ Tregs. However, when the amount of fetal-maternal HLA mismatches was related to the percentage of FOXP3+ Tregs, the Tregs were significantly higher in pregnancies with 4–6 HLA class I mismatches (n = 16), than in those with 0–3 HLA class I mismatches (n = 38; p = 0.029). Furthermore, OD pregnancies express less interleukin 10, interleukin 6, galectin–1 and Flt–1 in the decidua basalis compared to NC pregnancies. Moreover, the amount of interleukin 10 was significantly lower with 3–4 fetal-maternal HLA class II mismatches (p = 0.032). Limitations, reasons for caution This study is limited by a small sample size. Moreover, only term placentas were collected. It would be worthwhile investigating immunological alterations in the decidua throughout the whole gestation, since maternal adaptation of the fetal allograft could be more prominent early in pregnancy. Wider implications of the findings: Unravelling the mechanisms of immunomodulation during OD pregnancy, reflected by a high level of fetal-maternal dissimilarity, could help to reach the ultimate goal in transplantation; the induction of donor-specific tolerance. In addition, it might help to understand the development of complications in OD pregnancy. Trial registration number Not applicable


2008 ◽  
Vol 0 (0) ◽  
pp. 080428135811547-???
Author(s):  
Alessandro Granito ◽  
Marta Stanzani ◽  
Luigi Muratori ◽  
Dimitrios P. Bogdanos ◽  
Paolo Muratori ◽  
...  

BMJ Open ◽  
2019 ◽  
Vol 9 (7) ◽  
pp. e027469
Author(s):  
Kim van Bentem ◽  
Eileen Lashley ◽  
Manon Bos ◽  
Michael Eikmans ◽  
Sebastiaan Heidt ◽  
...  

IntroductionOocyte donation (OD) enables women with reproductive failure to conceive. Compared with naturally conceived (NC) and in vitrofertilisation (IVF) pregnancies, OD pregnancies are associated with a higher risk of pregnancy complications. The allogeneic nature of the fetus in OD pregnancies possibly plays a role in the development of these complications. The objective of the current study is therefore to study the number and nature of human leucocyte antigen (HLA) mismatches between fetus and mother and its association with the development of hypertensive pregnancy complications.Methods and analysisIn this prospective multicentre cohort study, 200 patients visiting one of the 11 participating fertility centres in the Netherlands to perform OD or embryo donation or surrogacy will be invited to participate. These patients will be included as the exposed group. In addition, 146 patients with a NC pregnancy and 146 patients who applied for non-donor IVF are included as non-exposed subjects. These groups are frequency matched on age and ethnicity and only singleton pregnancies will be included. The primary clinical outcome of the study is the development of hypertensive disease during pregnancy. Secondary outcomes are the severity of the pre-eclampsia, time to development of pre-eclampsia and development of other pregnancy complications. The association of high number of HLA mismatches (>5) between mother and fetus will be determined and related to clinical outcome and pregnancy complication.Ethics and disseminationThis study received ethical approval from the medical ethics committee in the Leiden University Medical Centre, the Netherlands (P16.048, ABR NL56308.058.16). Study findings will be presented at (inter) national conferences and published in peer-reviewed journals.


Diabetes ◽  
1999 ◽  
Vol 48 (5) ◽  
pp. 983-988 ◽  
Author(s):  
B. M. Brooks-Worrell ◽  
R. Juneja ◽  
A. Minokadeh ◽  
C. J. Greenbaum ◽  
J. P. Palmer

Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 2615-2615
Author(s):  
Susannah Helene Kassmer ◽  
Emanuela Bruscia ◽  
Ping-Xia Zhang ◽  
Diane S Krause

Abstract Abstract 2615 Since 1998, there have been many discoveries that bone marrow derived cells (BMDC) possess the ability to cross lineage barriers and differentiate into mature, non-hematopoietic cells of multiple tissues. In recent years, several studies demonstrated engraftment of BMDC as epithelial cells of the lung. One of the main unanswered questions is which population(s) of BMDC are responsible for this engraftment. Previous investigations reported a lack of marrow derived lung epithelial cells (MDLE) after transplantation of hematopoietic stem cells (Thy1loLSK), while others found MDLE in the lungs of mice undergoing whole bone marrow transplantation. We therefore hypothesized that primitive, non-hematopoietic stem cells residing in the BM are the source of MDLE, and tested directly whether nonhematopoietic bone marrow derived cells have the capacity to engraft as epithelial cells of the lung. To test this hypothesis, we used Vav-cre transgenic mice, in which Cre recombinase is expressed uniquely within cells of the hematopoietic lineage, to determine which BM cell populations can engraft as surfactant protein C (SPC) expressing type 2 pneumocytes in surfactant-protein-C-null (SPC-KO) mice. Live hematopoietic and non-hematopoietic BM cells were separated by FACS-sorting based on expression of YFP in cells from ROSA-YFP/Vav-Cre mice that express YFP only in cells committed to the hematopoiesis. YFP positive (hematopoietic) or YFP negative (non-hematopoietic) cells were transplanted into irradiated SPC-KO mice. For transplant recipients of YFP negative cells, 1 million whole bone marrow cells from a recipient type SPC-KO mouse were cotransplanted to provide hematopoietic rescue following irradiation. MDLE were assessed by detection of alveolar type 2 cells expressing wild type SPC, which could only be derived from the donor cells in SPC-KO recipients. Methods of detection included confocal microscopic analysis of sorted CD45 negative lung cells and tissue sections stained for SPC and epithelial specific cytokeratin or TTF1 by immunofluorescence. In addition, isolated lung cells were stained in suspension and analyzed for donor derived type 2 cells by Imagestream technology for expression of SPC and cytokeratin. SPC positive type 2 cells were found in the lungs of 4 out of 6 mice receiving YFPnegative, non-hematopoietic BM cells, with 1 out of 16,000 total nucleated cells expressing SPC on lung tissue sections. In contrast, donor derived SPC positive type 2 pneumocytes were exceedingly rare in mice receiving YFPpositive, hematopoietic cells and were found in just 1 out of 9 mice, with only 1 out of 144,000 total nucleated cells being positive for SPC on tissue sections. These findings were confirmed by highly sensitive RT-PCR for wild type SPC mRNA. We conclude that the non-hematopoietic fraction of murine BM contains cells capable of engrafting as epithelial cells of the lung. Our data support the hypothesis of a primitive, pluripotent stem cell population residing in adult bone marrow. Disclosures: No relevant conflicts of interest to declare.


2008 ◽  
Vol 0 (0) ◽  
pp. 080326033328262-???
Author(s):  
Alessandro Granito ◽  
Marta Stanzani ◽  
Luigi Muratori ◽  
Dimitrios P. Bogdanos ◽  
Paolo Muratori ◽  
...  

2021 ◽  
Vol 12 (1) ◽  
pp. 67-75
Author(s):  
Alessandro Granito ◽  
Simona Pascolini ◽  
Chiara Ricci ◽  
Marco Ferronato ◽  
Luigi Muratori ◽  
...  

Background: Autoimmune hepatitis (AIH) is a chronic and aggressive liver disease that rapidly evolves into cirrhosis and end-stage liver disease if not timely diagnosed and treated with immunosuppressive therapy. AIH is classified into type 1 and type 2 according to the autoantibody pattern, with smooth muscle antibodies and/or antinuclear antibodies as serological markers of AIH-1, while antiliver cytosol antibody type 1 and/or antiliver/kidney microsomal antibody type 1 characterize type 2 AIH, which mainly affects children, including infants, and adolescents. Case Summary: We describe a case of type 2 AIH, clinically onset in a 34-year-old woman with decompensated cirrhosis. Only a thorough analysis of the autoantibody profile allowed for a diagnosis of an AIH-2 evolved into cirrhosis. The patient received a moderate corticosteroid therapy without achieving optimal disease control. We discuss the controversial decision of whether or not to treat the patient with immunosuppressive therapy, which should be balanced with the potential risk of infectious and other complications. A review of the literature on the management of patients with autoimmune cirrhosis is also presented. Conclusions: AIH-2 can be clinically onset in adult patients with cirrhosis and its complications, without being preceded by major clinical signs. Due to the difficult management of cirrhosis with immunosuppressive treatments, a patient-tailored strategy with a case-by-case approach is needed to prevent major complications such as infections, potentially precluding liver transplantation the only curative therapy.


2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
X Tian ◽  
K T S Aiyer ◽  
H M Kapsenberg ◽  
D L Roelen ◽  
M L V D Hoorn ◽  
...  

Abstract Study question Do quantity and composition of decidual macrophages differ between uncomplicated oocyte donation (OD) pregnancies and non-OD in vitro fertilization (IVF) pregnancies? Summary answer OD placentas show higher decidual CD163 positive fraction within the total macrophage population compared to non-OD IVF placentas. What is known already The embryo of an OD pregnancy is completely allogeneic to the mother, which may lead to a bigger challenge for the maternal immune system to tolerize the fetus compared to autologous pregnancies. Placental macrophages may be essential in maintaining a healthy pregnancy. Macrophages can be classified into different categories based on phenotype and characteristics, in which type 2 macrophages are thought to exhibit immune suppressive activity. Study design, size, duration This retrospective case-control study included patients who delivered in the Leiden University Medical Center between January 1st 2006 and July 1st 2016. A total of 42 pregnancies were enrolled in this study, conceived by uncomplicated singleton OD pregnancies (n = 25) or non-OD IVF pregnancies (n = 17). Medical records were reviewed and clinical data were collected. Placental tissue samples were collected for immunohistochemical staining and blood samples were collected for HLA typing. Participants/materials, setting, methods Placentas were collected and immunohistochemically stained for CD14 (pan-macrophage marker) and CD163 (type 2 macrophage marker). The extent of staining was quantitated by digital image analysis software. To assess mismatching, maternal and fetal DNA was typed for HLA-A, -B, C, -DRB1, and -DQB1. Main results and the role of chance A significantly lower percentage of CD14 positive staining was observed in the decidua basalis of OD pregnancies compared to non-OD IVF pregnancies (p = 0.030). Consequently, the CD163/CD14 ratio in OD group was higher than in non-OD IVF group (p = 0.243). In the parietalis, OD pregnancies demonstrated a significantly higher percentage of CD163+ staining (p = 0.040) and a significantly higher CD163/CD14 ratio (p = 0.032) compared to non-OD IVF group. The reproducibility of this quantitative analysis was found to be high. OD group was separated into a syngeneic group (number of mismatches lower than half of the antigens per HLA locus) and an allogeneic group (number of mismatches higher than half of the antigens per HLA locus). Significant differences of CD163+ and CD163/CD14 ratio were found in the decidua parietalis when comparing the HLA-classII-allogeneic OD group with the non-OD IVF group (p = 0.047). This difference was not found for the HLA-class-II-syngeneic OD group. Limitations, reasons for caution Our study only focused on decidua basalis and parietalis, no other locations in the placentas. Larger sample size might be needed to verify the association between macrophages and HLA mismatches. Wider implications of the findings To our knowledge, this study is the first to quantify a higher CD163 positive M2 macrophages load within the total decidual macrophages of uncomplicated OD pregnancy compared to non-OD IVF pregnancies. Trial registration number not applicable


2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
X Tian ◽  
K T S Aiyer ◽  
H M Kapsenberg ◽  
D L Roelen ◽  
M L V D Hoorn ◽  
...  

Abstract Study question Do quantity and composition of decidual macrophages differ between uncomplicated oocyte donation (OD) pregnancies and non-OD in vitro fertilization (IVF) pregnancies? Summary answer OD placentas show higher decidual CD163 positive fraction within the total macrophage population compared to non-OD IVF placentas. What is known already The embryo of an OD pregnancy is completely allogeneic to the mother, which may lead to a bigger challenge for the maternal immune system to tolerize the fetus compared to autologous pregnancies. Placental macrophages may be essential in maintaining a healthy pregnancy. Macrophages can be classified into different categories based on phenotype and characteristics, in which type 2 macrophages are thought to exhibit immune suppressive activity. Study design, size, duration This retrospective case-control study included patients who delivered in the Leiden University Medical Center between January 1st 2006 and July 1st 2016. A total of 42 pregnancies were enrolled in this study, conceived by uncomplicated singleton OD pregnancies (n = 25) or non-OD IVF pregnancies (n = 17). Medical records were reviewed and clinical data were collected. Placental tissue samples were collected for immunohistochemical staining and blood samples were collected for HLA typing. Participants/materials, setting, methods Placentas were collected and immunohistochemically stained for CD14 (pan-macrophage marker) and CD163 (type 2 macrophage marker). The extent of staining was quantitated by digital image analysis software. To assess mismatching, maternal and fetal DNA was typed for HLA-A, -B, C, -DRB1, and -DQB1. Main results and the role of chance A significantly lower percentage of CD14 positive staining was observed in the decidua basalis of OD pregnancies compared to non-OD IVF pregnancies (p = 0.030). Consequently, the CD163/CD14 ratio in OD group was higher than in non-OD IVF group (p = 0.243). In the parietalis, OD pregnancies demonstrated a significantly higher percentage of CD163+ staining (p = 0.040) and a significantly higher CD163/CD14 ratio (p = 0.032) compared to non-OD IVF group. The reproducibility of this quantitative analysis was found to be high. OD group was separated into a syngeneic group (number of mismatches lower than half of the antigens per HLA locus) and an allogeneic group (number of mismatches higher than half of the antigens per HLA locus). Significant differences of CD163+ and CD163/CD14 ratio were found in the decidua parietalis when comparing the HLA-classII-allogeneic OD group with the non-OD IVF group (p = 0.047). This difference was not found for the HLA-class-II-syngeneic OD group. Limitations, reasons for caution Our study only focused on decidua basalis and parietalis, no other locations in the placentas. Larger sample size might be needed to verify the association between macrophages and HLA mismatches. Wider implications of the findings: To our knowledge, this study is the first to quantify a higher CD163 positive M2 macrophages load within the total decidual macrophages of uncomplicated OD pregnancy compared to non-OD IVF pregnancies. Trial registration number Not applicable


Sign in / Sign up

Export Citation Format

Share Document